KAHIRA PHARMACEUTICALS & CHEMICAL INDUSTRIES COMPANY

Kahira Pharmaceuticals & Chemical Industries Company

CPCI

EGS38391C016

Pharmaceuticals

End-of-day quote Egyptian Exchange Other stock markets 23:00:00 27/05/2024 BST			5-day change	1st Jan Change
69.19 ^EGP	0.00%		0.00%	+22.35%

2023	Kahira Pharmaceuticals & Chemical Industries Company Reports Earnings Results for the First Quarter Ended September 30, 2023	CI
2023	Kahira Pharmaceuticals & Chemical Industries Company Reports Earnings Results for the Full Year Ended June 30, 2023	CI

Kahira Pharmaceuticals & Chemical Industries Company Announces Earnings Results for the Nine Months Ended March 31, 2017

May 14, 2017

Kahira Pharmaceuticals & Chemical Industries Company announced earnings results for the nine months ended March 31, 2017. For the period, the company reported net profit of EGP 71,862,832 against EGP 33,000,429 a year ago.

Latest news about Kahira Pharmaceuticals & Chemical Industries Company

Kahira Pharmaceuticals & Chemical Industries Company Reports Earnings Results for the First Quarter Ended September 30, 2023	12-11	CI
Kahira Pharmaceuticals & Chemical Industries Company Reports Earnings Results for the Full Year Ended June 30, 2023	09/10/23	CI
Kahira Pharmaceuticals & Chemical Industries Company Reports Earnings Results for the Nine Months Ended March 31, 2023	23/05/23	CI
Kahira Pharmaceuticals & Chemical Industries Company Reports Earnings Results for the Full Year Ended June 30, 2022	21/09/22	CI
Kahira Pharmaceuticals & Chemical Industries Company Reports Earnings Results for the Third Quarter Ended March 31, 2022	24/05/22	CI
Kahira Pharmaceuticals & Chemical Industries Company Reports Earnings Results for the Third Quarter Ended March 31, 2022	24/05/22	CI
Kahira Pharmaceuticals & Chemical Industries Company Reports Earnings Results for the Half Year Ended December 31, 2021	14/02/22	CI
Kahira Pharmaceuticals & Chemical Industries Company Reports Earnings Results for the First Quarter Ended September 30, 2021	13/11/21	CI
Kahira Pharmaceuticals & Chemical Industries Company Reports Earnings Results for the Full Year Ended June 30, 2021	08/09/21	CI
Kahira Pharmaceuticals & Chemical Industries Company Reports Earnings Results for the Nine Months Ended March 31, 2021	10/06/21	CI
Cairo Pharmaceuticals Announces Audited Earnings Results for the Six Months Ended December 31, 2020	15/02/21	CI
Kahira Pharmaceuticals & Chemical Industries Company Reports Unaudited Earnings Results for the First Half of Fiscal Year 2020	10/02/20	CI
Kahira Pharmaceuticals Reports Earnings Results for the Fiscal Year 2019	29/09/19	CI
Cairo Pharmaceuticals Announces Audited Earnings Results for the Nine Months Ended March 31, 2019	14/05/19	CI
Cairo Pharmaceuticals Reports Earnings Results for the Six Months Ended December 31, 2018	16/02/19	CI
Cairo Pharmaceuticals Announces Reviewed Earnings Results for the Nine Months Ended September 30, 2018	13/11/18	CI
Cairo Pharmaceuticals Declares Cash Dividend Payable on October 28, 2018	09/10/18	CI
Cairo Pharmaceuticals Reports Earnings Audited Results for the Year Ended June 30, 2018	29/08/18	CI
Cairo Pharmaceuticals Reports Earnings Results for the Six Months Ended December 31, 2017	11/02/18	CI
Cairo Pharmaceuticals Announces Earnings Results for the First Quarter Ended on September 30, 2017	14/11/17	CI
Cairo Pharmaceuticals Declares Cash Dividends, Payable on October 26, 2017	07/10/17	CI
Cairo Pharmaceuticals Announces Audited Earnings Results for the Year Ended on June 30, 2017	09/09/17	CI
Kahira Pharmaceuticals & Chemical Industries Company Announces Earnings Results for the Nine Months Ended March 31, 2017	14/05/17	CI
Cairo Pharmaceuticals Reports Earnings Results for the Six Months Ended December 31, 2016	14/02/17	CI
Kahira Pharmaceuticals & Chemical Industries Co Reports Earnings Results for the First Half of Fiscal 2015	29/01/15	CI

Chart Kahira Pharmaceuticals & Chemical Industries Company

Duration

Period

Chart Kahira Pharmaceuticals & Chemical Industries Company

More charts

Company Profile

Cairo Pharmaceuticals specializes in manufacturing and marketing pharmaceutical products for the treatment of inflammatory, infectious, pulmonary, parasitic, dermatological, cardiovascular, allergic diseases, etc. The group also provides veterinary products.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
KAHIRA PHARMACEUTICALS & CHEMICAL INDUSTRIES COMPANY	+22.35%	21.71M
ELI LILLY AND COMPANY	+39.17%	727B
NOVO NORDISK A/S	+30.57%	592B
JOHNSON & JOHNSON	-7.80%	347B
MERCK & CO., INC.	+15.58%	319B
ABBVIE INC.	-0.50%	274B
ASTRAZENECA PLC	+12.55%	238B
NOVARTIS AG	+6.65%	204B
ROCHE HOLDING AG	-6.09%	203B
PFIZER, INC.	-3.02%	160B